Phase II study to evaluate the clinical efficacy and safety of MEDI4736 in patients with glioblastoma (GBM). Conference Paper uri icon

authors

  • Reardon, David A
  • Dietrich, Jorg
  • Kaley, Thomas Joseph
  • Gan, Hui Kong
  • Dunn, Gavin P
  • Cloughesy, Timothy Francis
  • Lim, Michael
  • Clarke, Jennifer Leigh
  • Park, Andrew J
  • Pan, Linda S
  • Lai, Dominic W
  • Karakunnel, Joyson Joseph
  • Robbins, Paul B
  • Narwal, Rajesh
  • Venhaus, Ralph Rudolph

publication date

  • May 20, 2015